EUVIMEDEUVIMED entdecken
Crossref

Response to botulinum toxin may predict response to peroral pyloromyotomy in patients with gastroparesis

Vaibhav Wadhwa, Adalberto Gonzalez iD, Francisco Azar, Harjinder Singh, Kapil Gupta, Hong Liang, Alison Schneider, Jeffery Ponsky, Tolga Erim, John Rodriguez, Fernando J Castro

Endoscopy · 01.06.2023 · 55 (06) · 508-514

DOI: 10.1055/a-1986-4292 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Endoscopy, erschienen am 01.06.2023. Verfasst von Vaibhav Wadhwa und 10 weiteren Autor:innen. Beteiligte Einrichtung: Center for Interventional Gastroenterology, University of Texas Health Science, Houston, Texas, United States. Hauptthemen laut MEDLINE: Gastroparesis, Pyloromyotomy, Botulinum Toxins. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 34 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Patients with gastroparesis who have undergone prior intrapyloric botulinum toxin injection (BTI) may seek an opinion regarding peroral pyloromyotomy (POP). There are only two small reports assessing the role of BTI as a predictor for successful treatment with POP.

Methods

We performed a retrospective cohort study to assess whether symptomatic improvement after BTI predicts a response to POP. We included 119 patients who had undergone both BTI and POP at Cleveland Clinic Ohio or Cleveland Clinic Florida from January 2016 to September 2019.

Results

65.5 % of patients had symptomatic improvement after BTI. Gastroparesis Cardinal Symptom Index (GCSI) scores were available for 74 patients, with 64 % achieving a response to POP, defined as a decrease in mean GCSI ≥ 1. In multivariable analysis, response to BTI (odds ratio [OR] 7.7 [95 %CI 2.2–26.1]) and higher pre-POP GCSI score (OR 2.3 [95 %CI 1.2–4.6]) were independent predictors of response to POP.

Conclusions

Clinical improvement after BTI is a predictor of response to POP in patients with gastroparesis. This information may aid in improving patient selection for POP.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GastroparesisPyloromyotomyBotulinum ToxinsHumansGastric EmptyingRetrospective StudiesTreatment Outcome

Substanzen

Botulinum Toxins

Autor:innen und Institutionen

  • Center for Interventional Gastroenterology, University of Texas Health Science, Houston, Texas, United States.
  • Department of Gastroenterology and Hepatology, Cleveland Clinic Florida, Weston, Florida, United States.
  • Department of Gastroenterology, Rutgers Robert Wood Johnson Medical School, New Brunswick, New Jersey, United States.
  • Department of Clinical Research, Cleveland Clinic Florida, Weston, Florida, United States.
  • Department of General Surgery, Digestive Disease and Surgery Institute, Cleveland Clinic, Cleveland, Ohio, United States.

ORCID-Profile: Adalberto Gonzalez

Zitieren

APA

Wadhwa, V., Gonzalez, A., Azar, F., Singh, H., Gupta, K., Liang, H., Schneider, A., Ponsky, J., Erim, T., Rodriguez, J., & Castro, F. J. (2023). Response to botulinum toxin may predict response to peroral pyloromyotomy in patients with gastroparesis. Endoscopy, 55(06), 508-514. https://doi.org/10.1055/a-1986-4292

Vancouver

Wadhwa V, Gonzalez A, Azar F, Singh H, Gupta K, Liang H, et al. Response to botulinum toxin may predict response to peroral pyloromyotomy in patients with gastroparesis. Endoscopy. 2023;55(06):508-514. doi:10.1055/a-1986-4292

BibTeX
@article{Wadhwa2023,
  author = {Wadhwa, Vaibhav and Gonzalez, Adalberto and Azar, Francisco and Singh, Harjinder and Gupta, Kapil and Liang, Hong and Schneider, Alison and Ponsky, Jeffery and Erim, Tolga and Rodriguez, John and Castro, Fernando J},
  title = {Response to botulinum toxin may predict response to peroral pyloromyotomy in patients with gastroparesis},
  journal = {Endoscopy},
  year = {2023},
  volume = {55},
  number = {06},
  pages = {508--514},
  doi = {10.1055/a-1986-4292}
}
Kostenlos starten →